About Aqurance
Aqurance is a Healthcare company based in Athens (Greece) founded in 2011, and was acquired by EY in October 2025. It offers Veeva implementations, data services, and consulting for pharmaceutical firms. It operates on a B2B model in Healthcare and Business Services sectors. Aqurance offers products and services including Veeva Implementations, Data Services, Business Analytics, and Commercial Services. Its focus areas include Life Sciences, Pharmaceutical Tech, R&D and Quality and Veeva Implementations.
Company details
Aqurance delivers end-to-end solutions for life sciences, specializing in Veeva Vault applications for RD, quality, and commercial operations. They assist pharmaceutical and biotech companies with data-powered transformations, CRM effectiveness, and digital marketing. Based in Athens, Greece, and London, UK, Aqurance optimizes workflows through expert implementations, data analysis, and strategic consulting to enhance business processes and drive growth.
- Headquarters Athens, Greece
- Stage Acquired
- SectorsHealthcareBusiness Services
- Email••••••••
- Website aqurance.com
- Social LinkedIn X Facebook
- Acquired by EY (Oct 2025)
Products & Services of Aqurance
Aqurance offers a comprehensive portfolio of products and services, including Veeva Implementations, Data Services, Business Analytics, and Commercial Services.
Provides expert Veeva platform setups for R&D and commercial operations.
Offers data cleansing, migration, and analysis for life sciences insights.
Delivers advanced data analysis to uncover trends in pharmaceutical data.
Enhances CRM and digital marketing for life sciences companies.
Investors in Aqurance
Aqurance has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include EY.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Assurance, tax, consulting, and transaction services are provided globally. | 1989 | ey.com | London, United Kingdom |
Investor details for Aqurance
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aqurance
2 dated milestones of Aqurance across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Aqurance is founded.
- Exit Acquired by EY.
Web traffic of Aqurance
The website of Aqurance (aqurance.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 18.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aqurance
Aqurance was founded in 2011.
Aqurance is headquartered in Athens, Greece.
Aqurance delivers end-to-end solutions for life sciences, specializing in Veeva Vault applications for RD, quality, and commercial operations. They assist pharmaceutical and biotech companies with data-powered transformations, CRM effectiveness, and digital marketing. Based in Athens, Greece, and London, UK, Aqurance optimizes workflows through expert implementations, data analysis, and strategic consulting to enhance business processes and drive growth.
Aqurance offers Veeva Implementations, Data Services, Business Analytics, and Commercial Services.
Aqurance has 1 investor. Key investors include EY.
Yes. Aqurance was acquired by EY in October 2025.